Agouti-Related Peptide

Overview

Agouti-Related Peptide (AgRP) is a 132-amino acid neuropeptide expressed in a highly restricted subset of neurons in the arcuate nucleus of the hypothalamus — the AgRP/NPY neurons — and is one of the most potent orexigenic (appetite-stimulating) neuropeptides known. It was identified in 1997 by Ollmann, Barsh, and colleagues based on its sequence similarity to the skin-pigmentation gene product agouti signaling protein (ASIP), which has a well-characterized role in coat color variation in mice and other mammals.

The relationship to agouti signaling protein is instructive. ASIP acts in skin melanocytes as an antagonist of melanocortin MC1 receptor, blocking α-MSH-induced eumelanin production and thereby producing the pheomelanin-rich yellow coat of the "agouti" mouse. AgRP retains the disulfide-rich C-terminal domain of ASIP but is expressed in the brain rather than skin, and it acts as an antagonist — more precisely, an inverse agonist — at MC3 and MC4 melanocortin receptors, the principal CNS melanocortin receptor subtypes regulating feeding behavior and energy homeostasis.

AgRP is co-expressed with neuropeptide Y (NPY) in arcuate "AgRP/NPY" neurons, which together constitute the principal orexigenic circuit in the hypothalamus. These neurons are activated by fasting, by ghrelin, and by negative energy balance, and they drive hyperphagia through three parallel outputs: AgRP (MC4R inverse agonism), NPY (Y1/Y5 agonism), and GABA (direct inhibition of downstream anorexigenic POMC neurons). The AgRP/NPY pair is one of the most thoroughly characterized and conceptually important hypothalamic circuits, and optogenetic activation of AgRP neurons alone rapidly induces intense feeding in rodents.

Structure/Sequence

Human AgRP: Full-length 132-amino acid protein (signal peptide cleaved from 132-aa preproprotein)

AgRP(83-132), C-terminal fragment: Retains full MC4R inverse agonist activity; commonly used in research

• Length: 132 aa (full-length); 50 aa (C-terminal active fragment)
• Molecular weight: ~14 kDa (full); ~5.5 kDa (C-terminal fragment)
• Gene: AGRP (chromosome 16q22.1)
• Disulfide architecture: 10 cysteines in the C-terminal domain forming 5 intramolecular disulfide bonds
• Cystine knot fold: ICK-like fold reminiscent of plant defensins and invertebrate neurotoxins

C-Terminal Cystine Knot

The functional domain is the C-terminal ~50 amino acids with its multiple disulfide bonds. This compact, rigid scaffold has been compared to plant defensin folds and ω-conotoxin/agatoxin cystine-knot peptides, representing an unusual structural class among mammalian neuropeptides.

Critical Residues

• RFF triplet: Arg-Phe-Phe sequence in the C-terminal loop is a critical pharmacophore for MC4R binding
• Disulfide bonds: All five disulfides required for correct folding and activity
• Reduction eliminates activity: Cysteine reduction abolishes MC4R binding

Species Conservation

The C-terminal functional domain is highly conserved across mammals, reflecting strong selective pressure on this critical energy-balance signal.

Mechanism of Action

Melanocortin Receptor Inverse Agonism

AgRP binds MC3R and MC4R with high affinity and acts as an inverse agonist — it not only blocks α-MSH-induced activation but also suppresses the constitutive (ligand-independent) activity of these receptors. This makes AgRP more than a simple antagonist; it actively reduces MC4R signaling below baseline.

• MC3R: Inverse agonism; contributes to feeding and energy expenditure regulation
• MC4R: Primary target for appetite effects; strong inverse agonism produces robust orexigenic signal
• MC1R and MC5R: Minimal activity at peripheral melanocortin receptors

Appetite Stimulation

• ICV AgRP produces prolonged hyperphagia (effect outlasts administration for days)
• Peripheral administration has limited efficacy due to BBB
• Antagonizes satiety signaling from POMC/α-MSH neurons
• Integrates with leptin, ghrelin, and insulin signaling in hypothalamus

Arcuate Circuit Architecture

AgRP/NPY neurons in the arcuate nucleus:

• Express leptin receptors (ObRb) — inhibited by leptin
• Express ghrelin receptor (GHS-R1a) — activated by ghrelin
• Express insulin receptor — inhibited by insulin
• Release three transmitters: AgRP (peptide, slow), NPY (peptide, fast), GABA (classical transmitter, fast)
• Project to paraventricular nucleus, lateral hypothalamus, and other targets

Optogenetic and Chemogenetic Studies

• Stimulating AgRP neurons induces feeding within minutes, even in well-fed mice
• Silencing AgRP neurons reduces food intake
• Constitutive ablation of AgRP neurons in adults causes starvation
• These experiments established AgRP/NPY neurons as the core orexigenic hypothalamic node

Endocrine Effects

• AgRP influences HPG axis, thyroid function, and autonomic outflow through MC3/4R signaling
• Role in reproductive function in severe negative energy balance

Pharmacological Antagonism

Selective MC4R agonists (like setmelanotide) effectively overcome AgRP-mediated MC4R blockade, restoring POMC/α-MSH-like satiety signaling. This is the basis for setmelanotide's clinical use in genetic obesity with leptin pathway defects upstream of AgRP.

Research Summary

Common Discussion Topics

1. Inverse agonism at MC4R — AgRP is one of the clearest examples of endogenous inverse agonism in mammalian neuropeptide biology. Because MC4R has constitutive (ligand-independent) activity, AgRP's ability to suppress this baseline signaling — not just block agonist effects — gives it extra physiological potency.

2. AgRP/NPY circuit model — The AgRP/NPY neuron is one of the most completely characterized single-circuit nodes in behavioral neuroscience. Its activation drives intense feeding; its ablation causes starvation. The circuit's responsiveness to leptin, ghrelin, and insulin makes it a central hub for metabolic sensing.

3. Cystine knot structural class — AgRP's compact disulfide-rich fold is unusual among mammalian signaling peptides. It is structurally more similar to plant defensins and invertebrate toxins than to most vertebrate neuropeptides, illustrating how protein folds can cross kingdoms and functional categories.

4. Therapeutic target architecture — The AgRP ↔ α-MSH ↔ MC4R circuit has been successfully targeted therapeutically. Setmelanotide activates MC4R directly, bypassing upstream defects in leptin-melanocortin signaling that reduce α-MSH but not AgRP, restoring the signal balance toward satiety.

5. Agouti coat color connection — The sequence similarity between AgRP and skin agouti signaling protein, along with their shared mechanism of melanocortin receptor antagonism, is a striking example of a gene family co-opted for a completely different physiological role in different tissues (feeding vs pigmentation).

Related Compounds

• α-MSH — the endogenous MC3R/MC4R agonist opposed by AgRP
• Neuropeptide Y — co-expressed orexigenic peptide in AgRP/NPY neurons
• Leptin — upstream regulator suppressing AgRP/NPY activity
• Setmelanotide — MC4R agonist used to overcome AgRP signaling defects
• PT-141 — another MC3R/MC4R-active peptide